Na Yang

WJD008, a Dual Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin Inhibitor, Prevents PI3K Signaling and Inhibits the Proliferation of Transformed Cells with Oncogenic PI3K Mutant

Jian Ding, Lin-jiang Tong, Linghua Meng, 2010, Journal of Pharmacology and Experimental Therapeutics.

Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer

Yi Chen, Jian Ding, Lin-jiang Tong, 2010, Journal of Molecular Medicine.

S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton

Hualiang Jiang, Jian Ding, C. Luo, 2009, PloS one.

c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner.

Z. Miao, Jian Ding, Bing Yu, 2009, Cancer research.

MT119, a new planar‐structured compound, targets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation

Yi Chen, Z. Miao, Jian Ding, 2011, International journal of cancer.

MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition

Z. Miao, Jian Ding, Lin-jiang Tong, 2009, Journal of cellular and molecular medicine.

Abstract #3391: S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton

Hualiang Jiang, Jian Ding, C. Luo, 2009 .